Exact Mass: 394.258

Exact Mass Matches: 394.258

Found 49 metabolites which its exact mass value is equals to given mass value 394.258, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DHT benzoate

Dihydrotestosterone benzoate

C26H34O3 (394.2508)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

LysoPA(P-16:0/0:0)

[(2R)-3-[(1Z)-hexadec-1-en-1-yloxy]-2-hydroxypropoxy]phosphonic acid

C19H39O6P (394.2484)


1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. 1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is irreversibly produced from 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine via the enzyme alkylglycerophosphoethanolamine phosphodiesterase (EC: 3.1.4.39). Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 1-(1Z-hexadecenyl)-sn-glycero-3-phosphate is an intermediate of ether lipid metabolism. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.

   

1,6-Bis(cyclohexyloximinocarbonyl)hexane

N-[6-({[(cyclohexylideneamino)oxy](hydroxy)methylidene}amino)hexyl][(cyclohexylideneamino)oxy]carboximidate

C20H34N4O4 (394.258)


   

Stanolone benzoate

2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl benzoate

C26H34O3 (394.2508)


   

nor-Spiculoic acid A

(+)-nor-Spiculoic acid A

C26H34O3 (394.2508)


   

Heteranthin

Methyl-3-oxo-12-apo-epsilon,psi-caroten-12-oate

C26H34O3 (394.2508)


   

Sumilizer GM

Sumilizer GM

C26H34O3 (394.2508)


   

24-norspiculoic acid A

24-norspiculoic acid A

C26H34O3 (394.2508)


   

SCHEMBL17867116

SCHEMBL17867116

C20H34N4O4 (394.258)


   

(S)-carduusyne-C ethyl ester

(S)-carduusyne-C ethyl ester

C26H34O3 (394.2508)


   

MEGxp0_000928

MEGxp0_000928

C26H34O3 (394.2508)


   

cyclo(L-propyl-L-leucyl-L-alanyl-L-isoleucyl)

cyclo(L-propyl-L-leucyl-L-alanyl-L-isoleucyl)

C20H34N4O4 (394.258)


   

24-norisospiculoic acid A

24-norisospiculoic acid A

C26H34O3 (394.2508)


   

Arachidonoyl-1-thio-Glycerol

5Z,8Z,11Z,14Z-eicosatetraenyl,1-thio glycerol

C23H38O3S (394.2542)


   

LPA(P-16:0e/0:0)

1-(1Z-hexadecenyl)-sn-glycero-3-phosphate;LysoPA(dm16:0e)

C19H39O6P (394.2484)


   

PA(P-16:0/0:0)

1-(1Z-hexadecenyl)-glycero-3-phosphate

C19H39O6P (394.2484)


   

Latanoprost (free acid)-d4

Latanoprost (free acid)-d4

C23H30D4O5 (394.2657)


   

LPA O-16:1

1-(1Z-hexadecenyl)-glycero-3-phosphate

C19H39O6P (394.2484)


   

1-palmitylglycerone 3-phosphate

1-hexadecyl-glycerone 3-phosphate

C19H39O6P (394.2484)


A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as palmityl (hexadecyl).

   

2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate

2-(1,1-dimethylethyl)-6-[[3-(1,1-dimethylethyl)-2-hydroxy-5-methylphenyl]methyl]-4-methylphenyl acrylate

C26H34O3 (394.2508)


   

(4-ethoxyphenyl) 4-(4-pentylcyclohexyl)benzoate

(4-ethoxyphenyl) 4-(4-pentylcyclohexyl)benzoate

C26H34O3 (394.2508)


   

RHC-80267

1,6-Bis(cyclohexyloximinocarbonyl)hexane

C20H34N4O4 (394.258)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors

   

N-[4-(2,6-dimethylpiperidin-1-yl)butyl]-2-phenoxy-2-phenylacetamide

N-[4-(2,6-dimethylpiperidin-1-yl)butyl]-2-phenoxy-2-phenylacetamide

C25H34N2O2 (394.262)


   

3-(Hexadecyloxy)-2-oxopropyl dihydrogen phosphate

3-(Hexadecyloxy)-2-oxopropyl dihydrogen phosphate

C19H39O6P (394.2484)


   

1,3-Cyclohexanediol, 4-Methylene-5-[(2e)-[(1s,3as,7as)-Octahydro-1-(5-Hydroxy-5-Methyl-1,3-Hexadiynyl)-7a-Methyl-4h-Inden-4-Ylidene]ethylidene]-, (1r,3s,5z)

1,3-Cyclohexanediol, 4-Methylene-5-[(2e)-[(1s,3as,7as)-Octahydro-1-(5-Hydroxy-5-Methyl-1,3-Hexadiynyl)-7a-Methyl-4h-Inden-4-Ylidene]ethylidene]-, (1r,3s,5z)

C26H34O3 (394.2508)


   

Stanolone benzoate

Androstanolone 17-benzoate

C26H34O3 (394.2508)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

1-Hexadecyl-sn-glycero-3-phosphate(2-)

1-Hexadecyl-sn-glycero-3-phosphate(2-)

C19H39O6P-2 (394.2484)


   

[(3aR,4S,9bS)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone

[(3aR,4S,9bS)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone

C25H34N2O2 (394.262)


   

[(3aS,4R,9bR)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone

[(3aS,4R,9bR)-8-(1-cyclohexenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-cyclopentylmethanone

C25H34N2O2 (394.262)


   

1-(1Z-hexadecenyl)-glycero-3-phosphate

1-(1Z-hexadecenyl)-glycero-3-phosphate

C19H39O6P (394.2484)


   

1-Hexadecyl-sn-glycero-3-phosphate(2-)

1-Hexadecyl-sn-glycero-3-phosphate(2-)

C19H39O6P (394.2484)


A 1-alkyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-hexadecyl-sn-glycero-3-phosphate; major species at pH 7.3.

   
   

LPA P-16:0 or LPA O-16:1

LPA P-16:0 or LPA O-16:1

C19H39O6P (394.2484)


   
   

ethyl (8e,16s)-16-methoxytricos-8-en-4,6,17,19-tetraynoate

ethyl (8e,16s)-16-methoxytricos-8-en-4,6,17,19-tetraynoate

C26H34O3 (394.2508)


   

(1r,3r,3as,4s,5s,7as)-4,5,7-triethyl-1,3-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5s,7as)-4,5,7-triethyl-1,3-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

(1s,3s,3ar,4r,5s,7ar)-1,4,5-triethyl-3,7-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-1,4,5-triethyl-3,7-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

(1r,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H34O3 (394.2508)


   

4,5,7-triethyl-1,3-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

4,5,7-triethyl-1,3-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H34O3 (394.2508)


   

(1r,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-4-hydroxy-3b,6,6,9a,11a-pentamethyl-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C26H34O3 (394.2508)


   

ethyl 16-methoxytricos-8-en-4,6,17,19-tetraynoate

ethyl 16-methoxytricos-8-en-4,6,17,19-tetraynoate

C26H34O3 (394.2508)


   

3,4,5-triethyl-1,7-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

3,4,5-triethyl-1,7-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

1,4,5-triethyl-3,7-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

1,4,5-triethyl-3,7-dimethyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

(1s,3s,3ar,4r,5s,7ar)-3,4,5-triethyl-1,7-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-3,4,5-triethyl-1,7-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

(3s,6s,9s,14as)-3-[(2s)-butan-2-yl]-1,4,7-trihydroxy-6-methyl-9-(2-methylpropyl)-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

(3s,6s,9s,14as)-3-[(2s)-butan-2-yl]-1,4,7-trihydroxy-6-methyl-9-(2-methylpropyl)-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C20H34N4O4 (394.258)


   

(1r,3r,3as,4s,5r,7as)-4,5,7-triethyl-1,3-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5r,7as)-4,5,7-triethyl-1,3-dimethyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C26H34O3 (394.2508)


   

(3s,6s,9s,14as)-9-[(2s)-butan-2-yl]-1,4,7-trihydroxy-6-methyl-3-(2-methylpropyl)-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

(3s,6s,9s,14as)-9-[(2s)-butan-2-yl]-1,4,7-trihydroxy-6-methyl-3-(2-methylpropyl)-3h,6h,9h,12h,13h,14h,14ah-pyrrolo[1,2-a]1,4,7,10-tetraazacyclododecan-10-one

C20H34N4O4 (394.258)